WCMLymphoma Profile Banner
WCM Lymphoma Profile
WCM Lymphoma

@WCMLymphoma

Followers
2K
Following
689
Statuses
2K

The Weill Cornell Medicine Lymphoma Program seeks to enable people with lymphoma to have the best possible clinical outcome. https://t.co/VB4txzzqth

New York, NY
Joined March 2011
Don't wanna be here? Send us removal request.
@WCMLymphoma
WCM Lymphoma
1 day
Dr. Jia Ruan spoke with @VJHemOnc about a phase 2 #ClinicalTrial evaluating a novel triplet combination for mantle cell #lymphoma (#MCL):
0
1
3
@WCMLymphoma
WCM Lymphoma
4 days
RT @WeillCornell: This year’s World Cancer Day theme is "United by Unique." Our collaborative approach to cancer care ensures patients rece…
0
16
0
@WCMLymphoma
WCM Lymphoma
5 days
LISTEN: Dr. Jia Ruan participated in the @VJHemOnc #podcast to discuss non-Hodgkin #Lymphoma updates from the 2024 @ASH_Hematology Annual Meeting
0
1
9
@WCMLymphoma
WCM Lymphoma
8 days
RT @YLeyfman: Presentation:
Tweet media one
Tweet media two
0
3
0
@WCMLymphoma
WCM Lymphoma
12 days
Watch Dr. Peter Martin discuss #PrecisionMedicine for the treatment of follicular #Lymphoma in this @CCO_Education video and earn #CME credit:
0
1
7
@WCMLymphoma
WCM Lymphoma
19 days
RT @OncLive: Join us on January 28, 2025, at 7:00 PM ET for an engaging conversation on global treatment strategies for Hodgkin lymphoma. @…
0
6
0
@WCMLymphoma
WCM Lymphoma
1 month
Hear from Dr. Peter Martin via @OncLive on the role of Bruton’s tyrosine kinase (BTK) inhibitor-based combinations as the future of mantle cell #lymphoma (#MCL) treatment:
0
0
0
@WCMLymphoma
WCM Lymphoma
1 month
Dr. John Allan recently spoke with @cure_today about understanding treatment options for relapsed/refractory chronic lymphocytic leukemia (#CLL):
1
0
2
@WCMLymphoma
WCM Lymphoma
2 months
ICYMI: Dr. Erin Mulvey discussed the use of targeted therapies for the treatment of follicular #lymphoma and how these treatments have advanced care
0
2
2
@WCMLymphoma
WCM Lymphoma
2 months
Watch Dr. Peter Martin discuss the role of Bruton’s tyrosine kinase (BTK) inhibitors for mantle cell #lymphoma with @OncLive:
0
0
2
@WCMLymphoma
WCM Lymphoma
2 months
Dr. Erin Mulvey presented @ChemotherapyFnd #CFS2024 on recent treatment advances in follicular #lymphoma, including BTK inhibitors and CAR T-cell therapy: (cc: @OncLive)
0
3
5
@WCMLymphoma
WCM Lymphoma
2 months
At #ASH24, @WCMHemOncFellow Dr. Gaurav Varma (@GVarmaMD) was involved with a study looking at the combination regimen P-GVAD in recurrent #HodgkinLymphoma:
Tweet media one
0
2
2
@WCMLymphoma
WCM Lymphoma
2 months
.@LisaRoth_MD presented at #ASH24 on results of a phase 2 #ClinicalTrial looking at pembrolizumab #immunotherapy in children and young adults with #HodgkinLymphoma: #AYAlymphoma #pediatriclymphoma
Tweet media one
0
1
7
@WCMLymphoma
WCM Lymphoma
2 months
HemOnc fellow Dr. Gaurav Varma (@GVarmaMD) explains #research evaluating the effectiveness of antibiotic use during immune checkpoint inhibitor therapy on eventual autologous stem cell transplant outcomes for #HodgkinLymphoma patients: #ASH24
Tweet media one
0
3
3
@WCMLymphoma
WCM Lymphoma
2 months
RT @CaitieGribbinMD: @samyamshon @WCMHemOncFellow @WCMLymphoma So excited to be able to present this work and am grateful for all the mento…
0
3
0
@WCMLymphoma
WCM Lymphoma
2 months
RT @samyamshon: Dr @CaitieGribbinMD presented incredibly data on the role of follicular dendritic cells and the temporal relationship with…
0
7
0
@WCMLymphoma
WCM Lymphoma
2 months
Presented at #ASH24: Pre-clinical #research looking at how RPS15 mutations drive the development of chronic lymphocytic leukemia (#CLL). Dr. @etenhacken explains:
Tweet media one
0
0
3
@WCMLymphoma
WCM Lymphoma
2 months
Dr. Jia Ruan presented phase 2 #ClinicalTrial results at #ASH24 evaluating the effectiveness of two different therapy combinations for patients with mantle cell #Lymphoma (#MCL):
Tweet media one
0
2
9
@WCMLymphoma
WCM Lymphoma
2 months
Live from #ASH24: @CaitieGribbinMD presented on the role of follicular dendritic cells (FDCs) in follicular #Lymphoma
Tweet media one
0
1
3
@WCMLymphoma
WCM Lymphoma
2 months
Dr. Peter Martin commented on #research evaluating #Lymphoma patients who experience financial toxicity throughout their diagnosis and treatment experience: #ASH24
Tweet media one
0
0
0